Cargando…
In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973136/ https://www.ncbi.nlm.nih.gov/pubmed/31309627 http://dx.doi.org/10.1111/exd.14005 |
_version_ | 1783489984222724096 |
---|---|
author | Ribet, Virginie Nobile, Vincenzo Rossi, Ana Beatris |
author_facet | Ribet, Virginie Nobile, Vincenzo Rossi, Ana Beatris |
author_sort | Ribet, Virginie |
collection | PubMed |
description | Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in photoaged skin. Twenty healthy volunteers had defined skin areas randomized to receive a topical product containing 3 antioxidants (pre‐tocopheryl(®), retinaldehyde and glycylglycine ole‐amide), its vehicle and a positive antioxidant control cream. The products were applied daily for 30‐day period. The skin areas were exposed to a controlled dose of UVA rays, and the skin oxidative status was evaluated 4 and 24 hours post‐UVA exposure at D0 (basal value) and after 15 and 30 days of product application. Skin layers were collected by stripping, and antioxidant capacity was measured using the ferric reducing ability of a plasma assay. Lipid peroxidation (LPO) was assessed using the malonyldialdehyde test. The tested product significantly improved the skin antioxidant capacity after 15 and 30 days and significantly decreased the basal level of the skin LPO. The skin LPO level significantly decreased 4 and 24 hours after UVA exposure at 15 and 30 days. These findings were comparable to positive control treated sites and were significantly different from the vehicle and untreated sites. This minimally invasive methodology enabled a quantitative evaluation of potent antioxidant activity in situ in the stratum corneum reflecting real‐life skin conditions and confirming the benefits of the topical application of a product containing 3 antioxidants in the prevention of UVA‐induced oxidative damage. |
format | Online Article Text |
id | pubmed-6973136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69731362020-01-27 In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study Ribet, Virginie Nobile, Vincenzo Rossi, Ana Beatris Exp Dermatol Original Articles Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in photoaged skin. Twenty healthy volunteers had defined skin areas randomized to receive a topical product containing 3 antioxidants (pre‐tocopheryl(®), retinaldehyde and glycylglycine ole‐amide), its vehicle and a positive antioxidant control cream. The products were applied daily for 30‐day period. The skin areas were exposed to a controlled dose of UVA rays, and the skin oxidative status was evaluated 4 and 24 hours post‐UVA exposure at D0 (basal value) and after 15 and 30 days of product application. Skin layers were collected by stripping, and antioxidant capacity was measured using the ferric reducing ability of a plasma assay. Lipid peroxidation (LPO) was assessed using the malonyldialdehyde test. The tested product significantly improved the skin antioxidant capacity after 15 and 30 days and significantly decreased the basal level of the skin LPO. The skin LPO level significantly decreased 4 and 24 hours after UVA exposure at 15 and 30 days. These findings were comparable to positive control treated sites and were significantly different from the vehicle and untreated sites. This minimally invasive methodology enabled a quantitative evaluation of potent antioxidant activity in situ in the stratum corneum reflecting real‐life skin conditions and confirming the benefits of the topical application of a product containing 3 antioxidants in the prevention of UVA‐induced oxidative damage. John Wiley and Sons Inc. 2019-09-30 2019-11 /pmc/articles/PMC6973136/ /pubmed/31309627 http://dx.doi.org/10.1111/exd.14005 Text en © 2019 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Ribet, Virginie Nobile, Vincenzo Rossi, Ana Beatris In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title | In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title_full | In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title_fullStr | In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title_full_unstemmed | In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title_short | In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study |
title_sort | in situ antioxidant activity of a dermo‐cosmetic product: a randomized controlled clinical study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973136/ https://www.ncbi.nlm.nih.gov/pubmed/31309627 http://dx.doi.org/10.1111/exd.14005 |
work_keys_str_mv | AT ribetvirginie insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy AT nobilevincenzo insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy AT rossianabeatris insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy |